Achieve Life Sciences, Inc.

Go to Achieve Life Sciences, Inc. Website

$2.60

0.02 (0.78%)
Live
Previous Close

$2.58

Day Range

$2.52 - $2.645

Previous Day Range

$2.56 - $2.62

Market Cap

$126.7 million USD

Day Vol.

550930

Previous Day Vol.

500715

Currency

USD

Primary Exchange

Nasdaq

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been app...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Achieve Life Sciences completed a public offering of 15 million shares and accompanying warrants, raising $45 million to fund the development of cytisinicline, a potential treatment for nicotine dependence and smoking cessation.

Related tickers: ACHV.

Read Full Article

Achieve Life Sciences announced a public offering of 15 million shares and accompanying warrants at $3.00 per share, expecting to raise approximately $45 million to fund the development of cytisinicline, a potential treatment for nicotine dependence.

Related tickers: ACHV.

Read Full Article
Trending Tickers

Please sign in to view